OTCMKTS:TCNNF

Trulieve Cannabis Stock Forecast, Price & News

$39.35

+0.41 (+1.05 %)

(As of 05/14/2021 12:00 AM ET)

Add

Compare

Today's Range

$38.75

▼

$39.76

50-Day Range

$35.43

▼

$49.08

52-Week Range

$11.11

▼

$53.73

Volume211,900 shs

Average Volume454,166 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive TCNNF News and Ratings via Email

Sign-up to receive the latest news and ratings for Trulieve Cannabis and its competitors with MarketBeat's FREE daily newsletter.

About Trulieve Cannabis

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of March 16, 2021, the company operated through 83 dispensaries in the United States. The company is headquartered in Quincy, Florida.

Trulieve Cannabis Dips 1.6% on Mixed Q1
May 13, 2021 | msn.com

Cantor Remains 'Overweight' On Trulieve Cannabis Post Q1 Earnings, Praises Florida Operations
May 13, 2021 | feeds.benzinga.com

Trulieve Cannabis Hits $193.8M In Q1 Revenue, 13th Consecutive Profitable Quarter Following Harvest Merger
May 13, 2021 | msn.com

Stifel Nicolaus Increases Trulieve Cannabis (OTCMKTS:TCNNF) Price Target to $132.00
May 12, 2021 | americanbankingnews.com

Canaccord Genuity Raises Trulieve Cannabis (OTCMKTS:TCNNF) Price Target to $97.00
May 12, 2021 | americanbankingnews.com

Cantor Fitzgerald Cuts Trulieve Cannabis (OTCMKTS:TCNNF) Price Target to $76.00
May 12, 2021 | americanbankingnews.com

Trulieve CEO on $2.1B Harvest Health acquisition
May 11, 2021 | finance.yahoo.com

$2.1B blockbuster deal will take in Arizona's biggest marijuana company
May 11, 2021 | msn.com

Harvest, Arizona's largest cannabis company, to be acquired in $2B deal
May 11, 2021 | bizjournals.com

Trulieve Cannabis Corp. (TCNNF) Announces the Largest US Cannabis Transaction; Acquisition of Harvest Health & Recreation Inc.
May 10, 2021 | marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:TCNNF

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.trulieve.com

Phone850-480-7955

Employees4,455

Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings Date5/18/2021 (Estimated)

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.68 out of 5 stars

Medical Sector

320th out of 2,044 stocks

Drug Manufacturers - Specialty & Generic Industry

3rd out of 61 stocks

4.5 Analyst's Opinion

Consensus Rating
Trulieve Cannabis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 11 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $65.64, Trulieve Cannabis has a forecasted upside of 66.8% from its current price of $39.35.
Amount of Analyst Coverage
Trulieve Cannabis has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.9 Community Rank

Outperform Votes
Trulieve Cannabis has received 95 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Trulieve Cannabis has received 28 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Trulieve Cannabis has received 77.24% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Trulieve Cannabis and other stocks. Vote “Outperform” if you believe TCNNF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TCNNF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Trulieve Cannabis does not currently pay a dividend.
Dividend Growth
Trulieve Cannabis does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Trulieve Cannabis insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Trulieve Cannabis (OTCMKTS:TCNNF) Frequently Asked Questions

Is Trulieve Cannabis a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Trulieve Cannabis stock.
View analyst ratings for Trulieve Cannabis or view top-rated stocks.

What stocks does MarketBeat like better than Trulieve Cannabis?

Wall Street analysts have given Trulieve Cannabis a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Trulieve Cannabis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Trulieve Cannabis?

Trulieve Cannabis saw a increase in short interest in April. As of April 15th, there was short interest totaling 158,100 shares, an increase of 58.6% from the March 31st total of 99,700 shares. Based on an average trading volume of 751,000 shares, the days-to-cover ratio is presently 0.2 days.
View Trulieve Cannabis' Short Interest.

When is Trulieve Cannabis' next earnings date?

Trulieve Cannabis is scheduled to release its next quarterly earnings announcement on Tuesday, May 18th 2021.
View our earnings forecast for Trulieve Cannabis.

How has Trulieve Cannabis' stock been impacted by COVID-19?

Trulieve Cannabis' stock was trading at $7.70 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TCNNF shares have increased by 411.0% and is now trading at $39.3481.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for TCNNF?

11 Wall Street analysts have issued twelve-month price targets for Trulieve Cannabis' stock. Their forecasts range from $23.00 to $132.00. On average, they anticipate Trulieve Cannabis' stock price to reach $65.64 in the next year. This suggests a possible upside of 66.8% from the stock's current price.
View analysts' price targets for Trulieve Cannabis or view top-rated stocks among Wall Street analysts.

Who are Trulieve Cannabis' key executives?

Trulieve Cannabis' management team includes the following people:

Ms. Kimberly Rivers, Chair, Pres & CEO (Age 42, Pay $540.31k)
Mr. Alex D'Amico, Chief Financial Officer (Age 46, Pay $509.96k)
Mr. Eric Raymond Powers III, J.D., Chief Legal Officer (Age 51, Pay $282.44k)
Mr. Jason Barry Pernell, Chief Information Officer (Age 43)
Ms. Lynn Ricci, Director of Investor Relations & Corp. Communications (Age 54)
Ms. Victoria Walker, Director of Marketing & Community Relations (Age 36)
Mr. Timothy Morey, Chief Sales Officer (Age 58)
Ms. Valda Coryat, Chief Marketing Officer (Age 49)
Mr. Steven Ferrell, Director of HR (Age 50)
Ms. Ronda Sheffield, Chief HR Officer

Who are some of Trulieve Cannabis' key competitors?

Some companies that are related to Trulieve Cannabis include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of TCNNF's competitors.

What is Trulieve Cannabis' stock symbol?

Trulieve Cannabis trades on the OTCMKTS under the ticker symbol "TCNNF."

How do I buy shares of Trulieve Cannabis?

Shares of TCNNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trulieve Cannabis' stock price today?

One share of TCNNF stock can currently be purchased for approximately $39.35.

How many employees does Trulieve Cannabis have?

Trulieve Cannabis employs 4,455 workers across the globe.

What is Trulieve Cannabis' official website?

The official website for Trulieve Cannabis is www.trulieve.com.

How can I contact Trulieve Cannabis?

The company can be reached via phone at 850-480-7955.

This page was last updated on 5/15/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Trulieve Cannabis Stock Forecast, Price & News

Adding

Adding

Adding Trulieve Cannabis Corp.

About Trulieve Cannabis

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

4.5 Analyst's Opinion

Consensus Rating

Price Target Upside/Downside

Amount of Analyst Coverage

3.9 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment